Long Term Benefits Of A Holistic Approach On Dyslipidaemia Management: Today For A Greater Future
Published: 19 February 2021
ESC and EAS guidelines brought several important new recommendations.
LDL-C control is still the first goal, but a single approach does not fit all patients.
Viatris' extensive portfolio can tackle various types of dyslipidaemias from early lifestyle reinforcement to very high-risk conditions. It is this holistic approach that we would like to share for a greater future for your patients.
Key Learning Objectives
- How to reach the LDL-C goals of high to very high-risk patients with combination therapy
- Red yeast rice supplementation
- How to differentiate EPA from Fenofibrates and how to manage hypertriglyceridemia with Fenofibrates
- Maciej Banach
- François Schiele
- Alberto Zambon
- Carlos Aguiar
More from this programme
Low-dosage red yeast rice supplementation in cholesterol control: review and expert opinion by ILEP
Are new LDL-C goals for ACS achievable in real life? How Registries could help?
Long term benefits of a holistic approach on dyslipidaemia management; today for a greater future
President of the Polish Mother's Memorial Hospital
Professor Maciej Banach is President of the Polish Mother's Memorial Hospital - Research Institute (PMMHRI), Head of the Cardiovascular Research Centre at University of Zielona Gora and Professor of Cardiology at the Medical University of Lodz (MUL) and PMMHRI in Poland.
Professor Schiele is Professor Of Cardiology at the University Hospital Besançon and Associate Professor of Cardiology at the Faculty of Medicine of the University of Franche Comté, Besançon, France.
Dr Carlos Aguiar is a staff physician in the Department of Cardiology at the Hospital Santa Cruz in Lisbon, Portugal.
Professor Alberto Zambon is Associate Professor of Medicine in the Department of Medicine, DIMED University of Padua School of Medicine, in Italy and also Affiliate Assistant Professor of Medicine in the Division of Endocrinology, Metabolism and Nutrition at the School of Medicine, University of Washington, Seattle in the USA.